developing AD. The method does not require a priori information about the tissue's optical properties.
To ensure the feasibility of our technique, we developed a theoretical model of photon propagation in the lumbar area to simulate the relationship between the measured fluorescence emission and the biomarkers' concentration ratio. We then used Monte-Carlo simulations to show that sufficient energy reaches the detector. We tested the accuracy of the method experimentally in vitro using multi-layered tissue phantoms. We prepared these with different scattering and absorption coefficients, thicknesses, and fluorescence concentrations to simulate variations in human anatomy and AD stages, as well as the needle location. We further tested the method's accuracy ex vivo using chicken breast tissue.
For in vitro experiments, we performed a total of 120 measurements on three-layered phantoms simulating the bone, CSF, and epidural fat layers. The bone layer was made of delrin (a synthetic polymer), and the epidural fat layer was made
Continued on next page
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of polyester resin with titanium dioxide. We modeled the CSF using a cuvette with fluorescent samples. We measured 15 fluorescent samples, varied in their concentration ratio, with eight different polyester slabs varying in thickness and scattering coefficient. Figure 2 presents the estimated versus true concentration ratio. Each data point is the average estimated value of eight measurements, using the different polyester slabs, with its 90% confidence interval. The mean absolute error of the 15 estimated values presented in Figure 2 is 4.4% with a standard deviation of 2.5%.
To better simulate the variations in the human spectra, we tested the method using four sets of ex vivo samples of chicken tissue. Figure 3 presents the estimated versus true concentration ratio. Each data point is the average estimated value of four measurements (performed on different excitation locations on the non-uniform tissue slab) with its 90% confidence interval. The mean absolute error of the estimated values presented in Figure  3 is 10.9% with a standard deviation of 7.8%.
We tested our method for optical detection of AD using fluorescent probes in the CSF with Monte Carlo simulations in in-vitro and ex-vivo experiments. These validated the possibility of accurately estimating the ratio of amyloid-beta and tau proteins in the CSF. The method does not require any a priori knowledge regarding the tissue's anatomical and optical properties and is performed without the need to penetrate the dura mater and collect CSF samples. Our next step is to demonstrate the method's accuracy in vivo and to verify its suitability as an annual screening test that will assist in the early diagnosis of AD.
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